Politico May 10, 2023
The agency is slated to make a decision on approval of the daily hormonal pill by this summer.
The Biden administration has long vowed to “follow the science” on drug approvals. But it has also pledged to aggressively defend reproductive rights.
Those two promises could clash this week as two FDA panels of expert advisers vote whether to recommend the agency approve the country’s first non-prescription birth control pill.